Multivalent butyrylcholinesterase inhibitor discovered by exploiting dynamic combinatorial chemistry
Shuang Zhao1, Jintao Xu1, Shixin Zhang1
1School of Pharmacy, Jiangsu University, 301 Xuefu Rd., Zhenjiang, China.
Researchers created a polymer dynamic combinatorial library (DCL) to find potent butyrylcholinesterase (BChE) inhibitors. The resulting multivalent inhibitor showed superior efficacy and selectivity against BChE compared to AChE.
Area of Science:
- Polymer Chemistry
- Medicinal Chemistry
- Enzyme Inhibition
Background:
- Cholinesterase enzymes, particularly butyrylcholinesterase (BChE) and acetylcholinesterase (AChE), are key targets in neurological disorders.
- Developing selective inhibitors for BChE is crucial for therapeutic applications, minimizing off-target effects.
Purpose of the Study:
- To synthesize a polymer-based dynamic combinatorial library (DCL) with exchangeable side chains.
- To identify potent BChE binding side chains using the DCL approach.
- To develop and evaluate a novel multivalent BChE inhibitor based on identified binding motifs.
Main Methods:
- Generation of a polymer-based DCL utilizing acylhydrazone formation for exchangeable side chains.
- Screening of the DCL in combination with tetrameric BChE to identify potent binding moieties.
- Synthesis of a multivalent inhibitor incorporating the identified BChE-specific side chains.
- In vitro evaluation of the multivalent inhibitor's efficacy and selectivity against BChE and AChE.
Main Results:
- Successful generation of a polymer-based DCL with tunable side chains.
- Identification of the most potent BChE binding side chain through library screening.
- Synthesis of a novel multivalent BChE inhibitor.
- The synthesized inhibitor demonstrated a superior inhibitory effect compared to a commercial reference.
- High selectivity was observed for BChE inhibition over AChE.
Conclusions:
- Polymer-based DCLs are effective tools for identifying potent enzyme inhibitors.
- The developed multivalent inhibitor represents a promising therapeutic candidate for BChE-related conditions.
- The study highlights the potential for selective BChE inhibition in drug discovery.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinesterases: Distribution and Function
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
